Eliseo Oreste Salinas - Net Worth and Insider Trading

Eliseo Oreste Salinas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eliseo Oreste Salinas owns 3 companies in total, including Relmada Therapeutics Inc (RLMD) , Microbot Medical Inc (MBOT) , and Passage Bio Inc (PASG) .

Click here to see the complete history of Eliseo Oreste Salinas’s form 4 insider trades.

Insider Ownership Summary of Eliseo Oreste Salinas

Ticker	Comapny	Transaction Date	Type of Owner
RLMD	Relmada Therapeutics Inc	2015-01-06	President and CSO
MBOT	Microbot Medical Inc	2013-06-06	EVP and Head of R&D
PASG	Passage Bio Inc	2021-03-22	Chief Res. & Develop Officer

Eliseo Oreste Salinas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eliseo Oreste Salinas Ownership Network

Ownership Network List of Eliseo Oreste Salinas

No Data

Ownership Network Relation of Eliseo Oreste Salinas

Eliseo Oreste Salinas Owned Company Details

What does Relmada Therapeutics Inc do?

Who are the key executives at Relmada Therapeutics Inc?

Eliseo Oreste Salinas is the President and CSO of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and Chief Medical Officer Cedric O'gorman .

Relmada Therapeutics Inc (RLMD) Insider Trades Summary

Over the past 18 months, Eliseo Oreste Salinas made no insider transaction in Relmada Therapeutics Inc (RLMD). Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 155,250 shares made by Sergio Traversa , a net purchase of 38,970 shares made by Chuck Ence , and a net purchase of 32,675 shares made by Maged Shenouda .

In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 236,895 shares were bought by its insiders, resulting in a net purchase of 236,895 shares.

Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Relmada Therapeutics Inc Insider Transactions

No Available Data

What does Microbot Medical Inc do?

Who are the key executives at Microbot Medical Inc?

Eliseo Oreste Salinas is the EVP and Head of R&D of Microbot Medical Inc. Other key executives at Microbot Medical Inc include Chief Financial Officer Rachel Vaknin , General Manager & CTO Simon Sharon , and director & 10 percent owner Yoseph Bornstein .

Microbot Medical Inc (MBOT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Microbot Medical Inc (MBOT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Microbot Medical Inc (MBOT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Microbot Medical Inc (MBOT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Microbot Medical Inc Insider Transactions

No Available Data

What does Passage Bio Inc do?

Who are the key executives at Passage Bio Inc?

Eliseo Oreste Salinas is the Chief Res. & Develop Officer of Passage Bio Inc. Other key executives at Passage Bio Inc include SVP & Interim CFO Kathleen Borthwick , Chief Medical Officer Mark S Forman , and Chief Financial Officer Simona King .

Passage Bio Inc (PASG) Insider Trades Summary

Over the past 18 months, Eliseo Oreste Salinas made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net sale of 13,506 shares made by Simona King , a net purchase of 1,192,577 shares made by Orbimed Advisors Llc , and a net sale of 5,000 shares made by Sandip Kapadia .

In summary, during the past 3 months, insiders sold 0 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,666 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 1,166,911 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Passage Bio Inc Insider Transactions

No Available Data

Eliseo Oreste Salinas Mailing Address

Above is the net worth, insider trading, and ownership report for Eliseo Oreste Salinas. You might contact Eliseo Oreste Salinas via mailing address: 7707 Gateway Blvd, Newark Ca 94560.

Discussions on Eliseo Oreste Salinas

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.